SCOOPBIG
Latest News,Shopping, Entertainment,Tech and Auto news
Search the site
MENU
Home / prnewswire
prnewswire Taj Pharma Launches VENOSTOR™ (Diosmin/Hesperidin Tablets) Unique Natural Formula MUMBAI, November 4, 2016 /PRNewswire/ -Taj Pharma's VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health. (Photo: http://photos.prnewswire.com/prnh/20161104/436235 ) VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. Treatment of venous disease Chronic venous disease (CVD) Hemorrhoidal disease (HD) Dietary supplement VENOSTOR 500 mg and 1000 mg (Micronized purified flavonoid fraction) Tablets:This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch) Diosmin/Hesperidin Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is converted by Web2PDFConvert.com
and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance. More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/ Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale. Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela. About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com Media Contact: Shantanu Singh s.k.singh@tajpharma.com +91-22-26374592 Taj Pharmaceuticals Ltd.
Back | Next story: LeEco Clocks Rs 350 Crore Revenue During October Festive Sales in Year 1 of India Operations
Latest News
converted by Web2PDFConvert.com
Mederi's Stretta Therapy for GERD approved in China NORWALK, Connecticut, an hour ago Mumbai Draws UAE Real Estate Player Deyaar to Property Show as Demand Rises Among Indian Investors MUMBAI, 2 hours ago Recovery in Western European Construction Boosts Growth Opportunities for PPE LONDON, 2 hours ago Thought Leaders Affirm the Need for Every Indian Household to Access Diverse Clean Cooking Solutions NEW DELHI, 4 hours ago Cleaner, More Efficient Coal-based Technologies Drive New Growth Opportunities in Power Generation CAPE TOWN, South Africa, 4 hours ago More news
POPULAR POSTS
RECENT POSTS
Uber vs Ola Taxi bill Comparison in Bangalore AUGUST 10, 2015 • 4 COMMENTS
Oops moment for Flipkart on big billion days sale 2015 OCTOBER 13, 2015 • 4 COMMENTS
Cognizant off campus drive for 2014 batch is on. JANUARY 23, 2015 • ONE COMMENT
Oops Moment 2 of Big Billion day from Flipkart OCTOBER 15, 2015 • ONE COMMENT
Stunning Action: Kid Skating under 45 Renault Dusters FEBRUARY 27, 2015 • NO COMMENT
converted by Web2PDFConvert.com
Subscribe to get your scoops Your email Address...
SUBSCRIBE
Popular Posts Scoop with us
Scoopbig Your email Address...
SUBSCRIBE
Recent Posts Tap it 12th results Tamilnadu Honda
Hyundai
AAP
india
Samsung galaxy a5 price
Activa
iphone 6
ATM Jobs
Saudi Freedom tower
Careers justin
cars Kejriwal
Scooters
Coupons Mexico
varanasi
Deal
DR. APJ Abdul Kalam
Microsoft
Workspace
Mitsubishi Wprdpress
Ford
Hero
Net Neutrality xbox
Nokia
Xcent
Scooping Scooping Select Category
Rss feeds Subscribe in a reader
scoopbig.com About us: Team together to bring all the news of Shopping, Technology, Auto point, Entertainment to Interesting News and Start ups.
Scoopbig Copyright © 2016. converted by Web2PDFConvert.com
Theme by Scoopbig
converted by Web2PDFConvert.com